CClinicalTrials.gg
CompletedNCT00205023Updated Nov 19, 2019

Disseminated Endometrial Cancer Cells During Sonohysterography

An interventional study of Sonohysterography in Endometrial Cancer, sponsored by University of Wisconsin, Madison. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-19.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The purpose of study is to: 1) determine critical volume necessary to overcome tubal pressure and result in fluid dissemination and 2) evaluate functional viability of any disseminated tumor cells collected during SHG

02

Conditions studied

  • Endometrial Cancer
03

In context

Endometrial Neoplasms

1,325 studies on the registry are indexed under Endometrial Neoplasms; 447 are open to participants now.

This study's enrollment of 25 is below the median of 70 across 941 interventional studies indexed under Endometrial Neoplasms.

Browse Endometrial Neoplasms studies →

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,161 studies on the registry; 182 are open to participants now.

Of its 151 completed or terminated interventional studies of FDA-regulated products, 114 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Stage I endometrial Cancer Disease
  • State IIA endometrial Cancer Disease

Exclusion criteria

Exclusion Criteria:

  • Prior tubal ligation
  • Prior bilateral salpingectomy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    A

    Procedure: Sonohysterography

Interventions

  • ProcedureSonohysterography

    SHG during surgery for endometrial cancer.

06

What researchers measure

Primary outcomes

  1. determine the critical volume necessary to overcome tubal pressure and result in fluid dissemination during SHG

    Time frame: during surgery

Secondary outcomes

  1. evaluate the functional viability of any disseminated tumor cells collected during SHG

    Time frame: during surgery

07

Study locations

1 site
  • University of Wisconsin
    Madison, Wisconsin 53792, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00205023
Lead sponsor
University of Wisconsin, Madison
Responsible party
Sponsor
First posted
Sep 20, 2005
Start date
Jan 2004
Primary completion
Feb 2006
Completion
Aug 2006
Last update
Nov 19, 2019

Study contacts

David M Kushner, MD
principal investigator · University of Wisconsin, Madison
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion